Bank of America’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.14K | Sell |
11,293
-4,153
| -27% | -$3.36K | ﹤0.01% | 6185 |
|
|
2025
Q1 | $11.9K | Sell |
15,446
-5,208
| -25% | -$4K | ﹤0.01% | 6049 |
|
|
2024
Q4 | $26.3K | Sell |
20,654
-4,290
| -17% | -$5.47K | ﹤0.01% | 5884 |
|
|
2024
Q3 | $51.6K | Sell |
24,944
-9,334
| -27% | -$19.3K | ﹤0.01% | 5642 |
|
|
2024
Q2 | $131K | Buy |
34,278
+2,014
| +6% | +$7.67K | ﹤0.01% | 5300 |
|
|
2024
Q1 | $153K | Sell |
32,264
-5,226
| -14% | -$24.8K | ﹤0.01% | 5181 |
|
|
2023
Q4 | $160K | Sell |
37,490
-15,157
| -29% | -$64.7K | ﹤0.01% | 5282 |
|
|
2023
Q3 | $163K | Buy |
52,647
+41,157
| +358% | +$127K | ﹤0.01% | 5143 |
|
|
2023
Q2 | $51.7K | Sell |
11,490
-16,696
| -59% | -$75.1K | ﹤0.01% | 5594 |
|
|
2023
Q1 | $161K | Sell |
28,186
-129,638
| -82% | -$739K | ﹤0.01% | 5249 |
|
|
2022
Q4 | $953K | Sell |
157,824
-9,654
| -6% | -$58.3K | ﹤0.01% | 4241 |
|
|
2022
Q3 | $1.11M | Buy |
167,478
+33,983
| +25% | +$225K | ﹤0.01% | 4130 |
|
|
2022
Q2 | $697K | Sell |
133,495
-1,742
| -1% | -$9.1K | ﹤0.01% | 4518 |
|
|
2022
Q1 | $933K | Buy |
135,237
+56,755
| +72% | +$392K | ﹤0.01% | 4670 |
|
|
2021
Q4 | $977K | Buy |
78,482
+71,387
| +1,006% | +$889K | ﹤0.01% | 4585 |
|
|
2021
Q3 | $222K | Buy |
7,095
+2,073
| +41% | +$64.9K | ﹤0.01% | 5395 |
|
|
2021
Q2 | $145K | Sell |
5,022
-11,399
| -69% | -$329K | ﹤0.01% | 5522 |
|
|
2021
Q1 | $711K | Buy |
16,421
+15,931
| +3,251% | +$690K | ﹤0.01% | 4509 |
|
|
2020
Q4 | $35K | Buy |
490
+480
| +4,800% | +$34.3K | ﹤0.01% | 5682 |
|
|
2020
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 6368 |
|